EAN Congress news

CME Topical symposium: Digital outcome assessment The symposium of digital outcome assessment had the aim to discuss objective measures performed by innovative digital techniques in different neurological diseases. Prof. Kappos started the symposium discussing about the “neurostatus-eEDSS” digitally measured in… Continue Reading

In recent years, much progress was made in understanding progressive MS bringing therapeutic options within sight. In this plenary symposium, the most important insights were highlighted.

EAN/EAPC Symposium 4: Palliative care and neurology Chairpersons:
Paul Boon, Ghent, Belgium
Philip Larkin, Dublin, Ireland Palliative care from a neurologist’s perspective: the evidence
David Oliver, Canterbury, United Kingdom Guidelines in progress across Europe
Raymond Voltz, Cologne, Germany What can… Continue Reading

Symposium 3: EAN/ESO: Cerebral small vessel disease – recent advances and clinical implications It’s Monday afternoon. You are reviewing results from your general neurology clinic. You recently saw a rather anxious patient with worsening headaches, which sounded probably migrainous, but… Continue Reading

This symposium was chaired by Prof. Reetta K. Kälviäinen, Kuopio, Finland, and Prof. Hannah Cock, London, United Kingdom. Overall, the symposium updated us about the link between genetic and epilepsy, and outlined the benefits and controversies regarding the use of genetical test in epilepsy.

Prof. T. Fleming Outeiro, from Goettingen, Germany, gave a very interesting lecture about “Tau protein in normal and pathological brain”.  He lectured on the misfolding of tau protein and its effects.  Protein folding and homeostasis remain a constant challenge for the normal cell. Tau is a complex microtubule binding protein.

Prof. Günther Deuschl, President of the EAN, also welcomed everybody. He highlighted some recent important studies published by European researchers, the celebration of the Brain Prize in Europe, and some EAN achievements such as the guidelines project. The EAN is also particularly interested in assessing the burden of neurological diseases in Europe.

In order to guarantee the quality of our upcoming congresses, we are carrying out congress evaluations. General Evaluation The general evaluation of the congress will be sent to all congress participants after the congress. Session Evaluation/CME Certificate If you wish… Continue Reading

The year of 1949 was a celebrating year for Neurosciences in Portugal, since our professor of Neurology Egas Moniz was awarded the Nobel Prize of Medicine and Physiology, an important recognition of his neuroscience research. This was a mark that very much inspired the interest of our medical school on neurosciences.

As in the previous years, EANpages asked EAN committee members, panel chairs, and invited speakers  which session one should not miss at the upcoming congress in Lisbon 2018. Please find their answers below!

All EAN individual members and members of scientific panels are invited to send proposals for topics/sessions for the 5th Congress of the EAN which will take place in Oslo, Norway, from June 29th to July 2nd, 2019! The aim is… Continue Reading

Starting at the EAN congress 2018 in Lisbon, the EAN Teaching Course sub-Committee has proposed to have an educating AND entertaining quiz-show. A dedicated taskforce together with the support of the EAN Scientific Panels worked on the set-up of this educational session – the EAN BrainChallenge.

As in the previous years, EANpages asked EAN committee members, panel chairs, and invited speakers  which session one should not miss at the upcoming congress in Lisbon 2018. Please find their answers below!   Rolf Fronczek, MD, PhD
Dept. of… Continue Reading

  Portugal has a long tradition in the study of behavioral disorders, dating back to the work of Egas Moniz and his attempt to improve some psychosis with psychosurgery. In the early 1970’s Antonio Damasio, who was taking his PhD… Continue Reading